Fundraising Fox
/Companies
Sign in

Silvec

Rockville, US · Founded 2019 · Delaware corporation · 14 employees on LinkedIn · 4 known investors

Find your way into Silvec

Sign up to see every warm intro you have to Silvec

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Silvec team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Silvec develops RNA-based therapies to protect trees, vines, and bushes from viral, bacterial, and fungal diseases without modifying the host genome. Its treatments use a proprietary type of RNA and are aimed at agricultural and horticultural crops such as citrus, olive, cacao, and banana trees.

AgTechBiotechDeep Tech

Founders & leadership

Silvec was founded in 2019 by Dr. Rafael Simon and Dr. Anne Simon.

DR
Dr. Rafael SimonCo-founder & President
DA
Dr. Anne SimonCo-founder & Chief Scientist
SP
Scott PundsackConsultant2022–2023Scott Pundsack is an intellectual property lawyer and patent agent with experience in international patent disputes and prosecution, licensed in the US and Canadian patent offices. He has served as senior counsel at a national law firm and fractional IP advisor to biotechnology startups, with expertise in drug delivery, medical devices, and clean technology.

Investors · 4

Maryland TEDCOlisted by Maryland TEDCOColumbia · $500K – $1.5M

How we know: Maryland TEDCO's portfolio page · Not right? Tell us

Orbia Ventureslisted by Orbia VenturesBoston · $1M – $6M
TEDCOlisted by TEDCOColumbia

Reported raises · per SEC filings

Form D private placements
▶$150KofferedJun 2021 · Agriculture
Rule 506(b)
Officers, directors & promoters on the filing
  • Anne SimonExecutive Officer
  • Scott PundsackExecutive Officer
  • Rafael SimonExecutive Officer, Director
Offering amount
$150K
Minimum investment
$25K
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MofferedDec 2020 · Agriculture
Rule 506(b)
Officers, directors & promoters on the filing
  • Anne SimonExecutive Officer
  • Rafael SimonExecutive Officer, Director
  • Scott PundsackExecutive Officer
Offering amount
$3M
Minimum investment
$25K
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Silvec do?
Silvec develops RNA-based therapies to protect trees, vines, and bushes from viral, bacterial, and fungal diseases without modifying the host genome. Its treatments use a proprietary type of RNA and are aimed at agricultural and horticultural crops such as citrus, olive, cacao, and banana trees.
Who founded Silvec?
Silvec was founded by Dr. Rafael Simon, Dr. Anne Simon in 2019.
Who are Silvec's investors?
Silvec's investors include Grosvenor Food & AgTech, Maryland TEDCO, Orbia Ventures, TEDCO.
Where is Silvec headquartered?
Silvec is headquartered in Rockville, US.